Differences Among the Elderly in the Treatment Costs of Colorectal Cancer
How Important Is Race
Datos Bibliográficos
| ID | 9104239 |
|---|---|
| Autores | George E Wright (0000-0002-5812-6533, autor de correspondencia), William E Barlow (0000-0003-4651-2282, Cancer Research And Biostatistics), Pamela Green (0009-0004-0517-3629, University of Washington, autor de correspondencia), Laura-Mae Baldwin, Laura–Mae Baldwin (University of Washington, autor de correspondencia), Stephen H Taplin (National Cancer Institute) |
| Año | 2007 |
| Volumen | 45 |
| Número | 5 |
| Páginas | 420-430 |
| Fecha de publicación | 2007-05-01 |
| Peer Reviewed | Sí |
| Open Access | No |
| Tipo | ARTICLE |
| Revista | Medical Care (JOURNAL) |
| Identificadores de la revista | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editorial | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/01.mlr.0000257184.93944.80 |
| PMID | 17446828 |
| PMCID | PMC3124338 |
| OpenAlex | W2035646602 |
| Idioma | EN |
| Citas recibidas | 1 |
| Referencias citadas | 30 |
BACKGROUND: Medical expenditures adjusted for price differences are a barometer of total resources devoted to patient care and thus may reflect treatment differentials. OBJECTIVE: We sought to estimate costs of the surgical and adjuvant treatment phases of colorectal cancer (CRC) care and cost differences by race (African American-white) and other patient characteristics. METHODS: We used the linked Surveillance, Epidemiology, and End Results (SEER)-Medicare database for stage II-III rectal and stage III colon cancer cases diagnosed in 1992-1996 to track Medicare approved payments for fee-for-service beneficiaries 66 and older in surgical (within 3 months of diagnosis) and postsurgical phases (13 months after the surgical phase). Net costs adjusted for expected noncancer expenditures were estimated with generalized linear models using pooled CRC and non-CRC cohorts. Using model results, we projected adjusted net costs for different patient groups (eg, by race, age). RESULTS: Total unstandardized CRC costs for African American recipients were $44,199, a statistically significant 15% higher than for white recipients ($38,378). Adjusting for covariates and expected non-CRC costs decreased the estimate for African American recipients to $34,588, a statistically insignificant $974 (2.9%) more than white recipients. Differential expenditures by age, urban-rural setting, region, and neighborhood median income were all much larger than differences by race, although only region was statistically significant. CONCLUSIONS: African American CRC patients cost more than their white counterparts, but adjusted differences were nonsignificant and trivial. Several nonracial cost differences were considerably larger (but not all statistically significant), and suggest that future research pay more attention to these characteristics
African american · Cancer · Colorectal cancer · Race (biology) · Colorectal Cancer Screening and Detection · Demography · Economic and Financial Impacts of Cancer · Epidemiology · Global Cancer Incidence and Screening · Internal Medicine · Medicine · Gerontology
Use of Census-based Aggregate Variables to Proxy for Socioeconomic Group
A Note on the Delta Method
Health-Based Risk Adjustment
Metropolitan, Urban, and Rural Commuting Areas
Working Class Matters
Overcoming the absence of socioeconomic data in medical records
Surgery for colorectal cancer
Obtaining Long-Term Disease Specific Costs of Care
Impact of Patient Socioeconomic Status on Physician Profiles
Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis
Utility of the Seer-Medicare Data to Identify Chemotherapy Use
Studying Radiation Therapy Using Seer-Medicare-Linked Data
Estimating Health Care Costs Related to Cancer Treatment From Seer-Medicare Data
Potential for Cancer Related Health Services Research Using a Linked Medicare-Tumor Registry Database
Patient Demographic and Socioeconomic Characteristics in the Seer-Medicare Database
Treatment Differences Between Blacks and Whites with Colorectal Cancer
| Obras citantes distintas | 1 |
|---|---|
| Citas por año | 1 |
| Intervalo de citas | 2026 - 2026 (1) |
| Velocidad de citación | current |
| Altamente citado | No |
| Tipos de cita | Neutras: 1 |